SLAS - Alexandra Csuport PhotographyLab Automation & ScreeningBiopharma transformation: growing impact of automation New AI tools and drug screening based on human cells and organoids promise a quantum leap in the success rate of drug development and in the processing of data from high-throughput analyses as well as … more ➔
EuroscreenFastAequorin TechnologyAequorin: superior choice for GPCR calcium signallingThe study of G protein-coupled receptor (GPCR) signalling is crucial for understanding a wide range of physiological processes. Among the methods used to monitor calcium signalling, Aequorin stands … more ➔
VALIDOGENBioprocess DevelopmentPichia protein productionRecombinant protein production in Pichia typically relies on AOX1 promoter-driven expression using methanol for induction. However, some companies avoid methanol due to safety concerns or operational … more ➔
Tebubio SASmRNA ProductionYour mRNA Partner in EuropeMessenger RNA (mRNA) has gained significant attention since being used in the Pfizer-BioNTech and Moderna COVID-19 vaccines. mRNA holds potential for preventing and treating many difficult-to-treat or … more ➔
Jeremy Levin, Ovid TherapeuticsBiosecure actThe West’s wake-up call to China’s biotech dominanceThe U.S. House of Representatives recently passed the BIOSECURE Act, prohibiting U.S. biopharma companies from working with Chinese contractors due to national security concerns, including data leaks … more ➔
Synthetic biologyBiology as SoftwareAt a recent event researcher and founder of Bit.bio, Prof. Mark Kotter, Babraham Research Campus in Cambridge/UK, was asked what healthcare looks like in 2050. He gave a twofold answer, that it will … more ➔
BiomanufacturingRichter-Helm – how CDMOs become strong partnersProfessionalism and quality are always at the forefront along the whole value chain: from gene to product. To pro-actively meet the evolving demand of the market to produce new assets Richter-Helm significantly … more ➔
BiomanufacturingA novel BPM systemThe biotech and pharma branch is growing steadily. Many companies have full order books for the next few years and expect growth. This is the basis for new investments in assets and infrastructure. These … more ➔
EuropeThe EU Commission strikes again – New patent ban?In times of the pandemic it was called to ban patents that are related to Covid-19 vaccines, medicaments, and diagnostics and the European Parliament was in favour of it. Now there is a call from the … more ➔
Biotech ClusterPaving the way to internationalisation Due to the global niche character of pharmaceutical biotechnology, research collaborations and market entries on an international level are essential. Agility and market knowledge are required to … more ➔
SLAS - Alexandra Csuport Photography
EuroscreenFast
VALIDOGEN
Tebubio SAS
Jeremy Levin, Ovid Therapeutics
